Abstract:The antagonism, stalemate and compromise between the immune system and tumor cells is closely associated with tumor development and progression. In recent years, tumor immunotherapy has made continuous breakthroughs. It has become an important approach for cancer treatment, improving the survival and prognosis of more and more tumor patients. Further investigating the mechanism of tumor immune regulation, and exploring tumor immunotherapy targets with high specificity and wide applicability will provide researchers and clinicians with favorable weapons towards cancer. Ubiquitination affects protein fate through influencing the activity, stability and location of target protein. The regulation of substrate protein fate by ubiquitination is involved in cell cycle, apoptosis, transcriptional regulation, DNA repair, immune response, protein degradation and quality control. E3 ubiquitin ligase selectively recruits specific protein substrates through specific protein-protein interactions to determine the specificity of the overall ubiquitin modification reaction. Immune-checkpoint inhibitory pathway is an important mechanism for tumor cells to evade immune killing, which can inhibit T cell activity. Blocking the immune checkpoints and activating T cells through targeting the negative regulatory factors of T cell activation and removing the "brake" of T lymphocytes can enhance T cells immune response against tumors. Therefore, blocking the immune checkpoint is one of the methods to enhance the activity of T cells, and it is also a hot target for the development of anti-tumor drugs in recent years, whose inhibitors have shown good effect in specific tumor treatment. Ubiquitination, as one of the most important post-translational modification of proteins, also modulates the expression, intracellular trafficking, subcellular and membranous location of immune checkpoints, regulating the immune surveillance of T cells to tumors.

Relationship between the velocity of rolling granulocytes and that of the blood flow in venules

Molecular characterization and expression analysis of the duck viperin gene.

Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

Targeting the Ubiquitin Pathway for Cancer Treatment

Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy

Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment

Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors

Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality

Emerging Role of DUBs in Tumor Metastasis and Apoptosis: Therapeutic Implication

Clinical and Marketed Proteasome Inhibitors for Cancer Treatment

Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression

The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy

Control of mTOR signaling by ubiquitin

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

A review of deubiquitinases and thier roles in tumorigenesis and development

Regulation of Cancer Immune Checkpoint: Mono- and Poly-Ubiquitination: Tags for Fate

Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors

Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy

Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers